India Glycols Limited (INDIAGLYCO) Price & Analysis

Compare

2 Followers

INDIAGLYCO Stock Chart & Stats

₹1007.65

-₹68.05(-5.10%)

At close: Jan 08 4:00 PM EST

₹1007.65

-₹68.05(-5.10%)

Day’s Range― - ―

52-Week Range₹502.50 - ₹1,222.85

Previous CloseN/A

Volume301.52K

Average Volume (3M)19.23K

Market Cap

₹58.82B

Enterprise Value₹78.75B

Total Cash (Recent Filing)₹774.40M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)21.0

Beta1.88

Next Earnings

Feb 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.47%

Share Statistics

EPS (TTM)10.25

Shares Outstanding67,026,764

10 Day Avg. Volume24,007

30 Day Avg. Volume19,229

Financial Highlights & Ratios

PEG Ratio0.23

Price to Book (P/B)0.79

Price to Sales (P/S)0.47

P/FCF Ratio-4.48

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Diversified Product PortfolioA broad product mix across glycols, glycol ethers, industrial alcohols and specialty chemicals reduces end-market concentration and cyclicality. This diversification supports steadier revenue streams, cross-selling, and resilience to sector-specific shocks over the next several months.

Sustained Revenue GrowthIndia Glycols has delivered double-digit top-line growth recently, indicating solid market demand and distribution reach. Even with deceleration, continued mid-to-high single digit to double-digit growth provides scale benefits and the potential to absorb fixed costs, supporting durable revenue momentum.

Improving Return On EquityAn improving ROE alongside a stable equity ratio suggests better capital deployment and a reasonable equity base. This enhances the firm's ability to generate shareholder returns from existing capital and supports reinvestment capacity without immediate dilution, a positive structural sign.

Bears Say

Rising LeverageHigher debt-to-equity raises financial risk and interest obligations, reducing flexibility to fund capex or absorb shocks. With leverage rising materially, the company faces durable refinancing and coverage risks that could constrain strategic options and increase vulnerability to demand swings.

Negative Free Cash FlowSustained negative free cash flow driven by high capital expenditure undermines internal funding for growth and deleveraging. Even with decent operating cash conversion, persistent negative FCF pressures liquidity and may force external financing or cutbacks, limiting strategic flexibility over months.

Margin PressureReported margin deterioration signals weaker earnings quality despite healthy gross margins. In a commodity-linked chemicals business, sustained margin pressure impairs ability to fund capex, reduces buffers against input cost swings, and can erode ROIC and long-term profitability if not addressed.

India Glycols Limited News

India Glycols Announces Trading Window Closure Ahead of Financial Results Meeting

India Glycols Limited ( ($IN:INDIAGLYCO) ) has shared an announcement. India Glycols Limited has announced the closure of...

3M ago

India Glycols Announces Dividend Post Share Split

India Glycols Limited ( ($IN:INDIAGLYCO) ) just unveiled an update. India Glycols Limited announced a dividend for the...

4M ago

INDIAGLYCO FAQ

What was India Glycols Limited’s price range in the past 12 months?

India Glycols Limited lowest stock price was ₹502.50 and its highest was ₹1222.85 in the past 12 months.

What is India Glycols Limited’s market cap?

India Glycols Limited’s market cap is ₹58.82B.

When is India Glycols Limited’s upcoming earnings report date?

India Glycols Limited’s upcoming earnings report date is Feb 06, 2026 which is in 5 days.

How were India Glycols Limited’s earnings last quarter?

India Glycols Limited released its earnings results on Nov 14, 2025. The company reported ₹10.25 earnings per share for the quarter, beating the consensus estimate of N/A by ₹10.25.

Is India Glycols Limited overvalued?

According to Wall Street analysts India Glycols Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does India Glycols Limited pay dividends?

India Glycols Limited pays a Annually dividend of ₹5 which represents an annual dividend yield of 0.47%. See more information on India Glycols Limited dividends here

What is India Glycols Limited’s EPS estimate?

India Glycols Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does India Glycols Limited have?

India Glycols Limited has 67,026,764 shares outstanding.

What happened to India Glycols Limited’s price movement after its last earnings report?

India Glycols Limited reported an EPS of ₹10.25 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.514%.

Which hedge fund is a major shareholder of India Glycols Limited?

Currently, no hedge funds are holding shares in IN:INDIAGLYCO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

India Glycols Limited

India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. The company operates through Industrial Chemical, Ethyl Alcohol, and Nutraceuticals segments. It offers monoethylene, diethylene, and triethylene glycols; polyethylene glycols; fatty alcohol, acid, and amine ethoxylates; alkyl phenol ethoxylates; castor/natural oil ethoxylates; and ethoxylated and propoxylated co-polymers. The company also provides polysorbates; glycol ethers and acetates; brake fluids and anti-freeze coolants; performance chemicals; natural gums, including guar gums and other hydrocolloid products; extra neutral alcohols/rectified spirits; Indian-made foreign liquor; and alcohol-based hand sanitizers. In addition, it offers natural active pharmaceutical ingredients, standardized botanical and herbal extracts, and spice extracts; and industrial gases, such as liquid oxygen, argon, nitrogen, and carbon dioxide, as well as IGL Steri-gas ethylene oxide and carbon dioxide gas mixtures. The company also exports its products. It serves agrochemical, automotive, detergent, healthcare and food processing, mining, oil and gas, paper, personal care, pharmaceutical, paint and emulsion polymerization, textile, and other industries. The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India.